This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Ptc Therapeutics, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Vijayalakshmi Gabbeta: Innovator in RNA Modulation
Introduction
Vijayalakshmi Gabbeta is a notable inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of RNA modulation, holding 2 patents that focus on innovative methods for altering RNA splicing.
Latest Patents
Her latest patents include "Methods for Modulating RNA Splicing" and "Methods for Modifying RNA Splicing." In these patents, she describes an intronic recognition element for splicing modifiers (iREMS) that can be recognized by specific compounds. The methods outlined aim to modulate the amount of gene products by utilizing these compounds to alter precursor RNA transcripts. Additionally, her work includes artificial gene constructs that incorporate intronic REMS to enhance protein production.
Career Highlights
Vijayalakshmi Gabbeta is currently employed at Ptc Therapeutics, Inc., where she continues to advance her research in RNA modulation. Her innovative approaches have the potential to impact various therapeutic applications, particularly in genetic research and treatment.
Collaborations
Some of her notable coworkers include Anuradha Bhattacharyya and Amal Dakka, who contribute to the collaborative environment at Ptc Therapeutics, Inc.
Conclusion
Vijayalakshmi Gabbeta's work in RNA modulation exemplifies the innovative spirit of modern science. Her patents reflect a commitment to advancing our understanding of gene expression and its implications for health and disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile